Heidi, a leading healthcare AI company, announced the closing of a $65 million Series B funding round. The round was led by Point72 Private Investments, with participation from existing investors Blackbird, Headline, and Latitude. This investment values Heidi at $465 million and brings total funding to nearly $100 million.

The funding will accelerate Heidi’s mission to deliver an AI Care Partner that assists clinicians by automating administrative tasks, clinical documentation, evidence searches, and follow-up communications. Research shows clinicians spend nearly as much time on administrative work as on patient care. In just 18 months, Heidi has returned over 18 million hours to frontline clinicians.

Dr. Thomas Kelly, CEO and co-founder of Heidi, said: “Healthcare demand is rising while clinical time is shrinking. Heidi builds an AI Care Partner to expand clinician capacity without compromising wellbeing or patient safety.”

Global Clinician Adoption and Impact

Over 200 medical specialties now use Heidi, supporting 73 million patient consults and over two million weekly consults in 110 languages across 116 countries. Heidi will expand its workforce, offices, and local support in the USA, UK, and Canada, and grow clinician-led adoption in France, Spain, Germany, Ireland, South Africa, Singapore, and Hong Kong.

Key healthcare partnerships include:

  • UK: Modality Partnership and Cambridge University Hospitals NHS Foundation Trust; pilots in North West London and Lancashire NHS Trusts.
  • USA: Beth Israel Lahey Health and MaineGeneral, the largest outpatient provider in Maine.
  • Canada: Official choice of the Yukon Government.
  • Australia: Monash Health and Queensland Health Children’s Hospital & Health Service.
  • New Zealand: Endorsed by the Health Ministry as a safe public health AI trial provider.

Investor Support and Executive Appointments

Point72 Private Investments’ Sri Chandrasekar said: “Heidi reduces administrative burden and burnout, helping clinicians focus on patient care while expanding system capacity.”

Heidi also appointed Paul Williamson as Chief Revenue Officer and Dr. Simon Kos as Chief Medical Officer. Williamson joins from Plaid, and Dr. Kos previously served as Chief Medical Officer at Microsoft.

Paul Williamson stated: “I’m excited to join Heidi’s mission to transform healthcare through AI, enabling clinicians to maximize clinical capacity.”

Dr. Simon Kos added: “Heidi improves clinician and patient experience, extending beyond ambient AI into a future where every clinician leverages AI without losing the human touch.”

Looking for more updates on financial innovation and revenue-driven technology? Visit RevTech News for expert insights and the latest trends.

News Source: Businesswire.com